SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QLT PhotoTherapeutics (QLTI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ian@SI who wrote (954)7/18/2000 7:14:38 PM
From: Stephen O  Read Replies (2) of 1321
 
Just being a devil's advocate but it seems as though people are thinking this way as of now. The share price of QLT is predicated on a certain cash flow stream for treatment way into the future. If something comes along in 2 years that affects that well the value of QLT shares drops. So even if Miravant is 2 years away 500,000 people, your number, can be treated with Visudyne by the specialists for the next 2 years but ongoing is not a certainty. And if the specialist is not paid by someone then most won't treat the penniless. Perhaps you can organise a charity to help pay the freight.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News